Kymera Therapeutics, Inc. (KYMR)

Kymera Therapeutics Revenue

Kymera Therapeutics had revenue of $22.10M in the quarter ending March 31, 2025, with 114.83% growth. This brings the company's revenue in the last twelve months to $58.89M, down -25.85% year-over-year. In the year 2024, Kymera Therapeutics had annual revenue of $47.07M, down -40.11%.

• Revenue (ttm): $58.89M
• Revenue Growth: -25.85%
• P/S Ratio: 58.46
• Revenue / Employee: $313,218
• Employees: 188
• Market Cap: 3.12B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	47.07M	-31.52M	-40.11%
Dec 31, 2023	78.59M	31.77M	67.84%
Dec 31, 2022	46.83M	-26.01M	-35.71%
Dec 31, 2021	72.83M	38.80M	114.00%
Dec 31, 2020	34.03M	31.10M	1,059.99%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.